Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes

The agenda of pharmacology discovery in the field of personalized oncology was dictated by the search of molecular targets assumed to deterministically drive tumor development. In this perspective, genes play a fundamental “causal” role while cells simply act as causal proxies, i.e., an intermediate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bizzarri, Mariano, Fedeli, Valeria, Monti, Noemi, Cucina, Alessandra, Jalouli, Maroua, Alwasel, Saleh H., Harrath, Abdel Halim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495186/
https://www.ncbi.nlm.nih.gov/pubmed/34642594
http://dx.doi.org/10.1007/s13167-021-00254-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495186/
https://www.ncbi.nlm.nih.gov/pubmed/34642594
http://dx.doi.org/10.1007/s13167-021-00254-1

Ejemplares similares